2019
DOI: 10.1080/02699052.2019.1683898
|View full text |Cite
|
Sign up to set email alerts
|

Follow-up after 5.5 years of treatment with methylphenidate for mental fatigue and cognitive function after a mild traumatic brain injury

Abstract: View related articles View Crossmark data Citing articles: 1 View citing articles Follow-up after 5.5 years of treatment with methylphenidate for mental fatigue and cognitive function after a mild traumatic brain injury

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
15
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 20 publications
(17 citation statements)
references
References 46 publications
2
15
0
Order By: Relevance
“…Such findings are consistent with those of previous dMRI studies that revealed correlations between reduced WM integrity in these areas and relatively low PS [96][97][98][99]. In mTBI, lower PS has been reported as early as 1-month post-injury and has been documented to persist for up to 6 years post-injury [100][101][102][103]. Commonly, lower PS is coexistent with other mTBI-related symptoms like fatigue, anxiety, and attention deficits.…”
Section: Ps Deficitssupporting
confidence: 91%
“…Such findings are consistent with those of previous dMRI studies that revealed correlations between reduced WM integrity in these areas and relatively low PS [96][97][98][99]. In mTBI, lower PS has been reported as early as 1-month post-injury and has been documented to persist for up to 6 years post-injury [100][101][102][103]. Commonly, lower PS is coexistent with other mTBI-related symptoms like fatigue, anxiety, and attention deficits.…”
Section: Ps Deficitssupporting
confidence: 91%
“…Eight had been receiving stimulant medication for approximately 5-6 years but had not taken methylphenidate for four weeks prior to inclusion in this study. Their cognitive test results and rating on MFS had returned to baseline after four weeks without methylphenidate [32]. All mTBI participants had recovered well and were independent in their daily lives, with the exception of their prolonged mental fatigue.…”
Section: Subjectsmentioning
confidence: 96%
“…By contrast, in two clinical trials amantadine had no effect on chronic cognitive dysfunction in patients with TBI [88]. Dextroamphetamine, a NE-DA reuptake inhibitor, showed no cognitive benefit in a randomized, placebo-controlled study [89], while methylphenidate promoted cognitive repair after TBI [90]. Chronic treatment with galantamine improved cognitive deficits after experimental TBI [91], but its therapeutic dose range was very narrow [92].…”
Section: Statinsmentioning
confidence: 97%